Pfizer submits early data on boosters' protection to FDA
The research shows that a third dose of their COVID-19 vaccine led to higher levels of antibodies if given 8 to 9 months after the initial two doses.
The research shows that a third dose of their COVID-19 vaccine led to higher levels of antibodies if given 8 to 9 months after the initial two doses.